Table 4.

Other factors and the association with difference in mean logMFI-BG, seroreversion and seroconversion.

Factor	N	Difference in mean logMFI-BG	P value	Rate of seroreversion	P value	Rate of seroconversion	P value
Age
≤ 5	992	− 0.17	0.17	10/232 (4.3)	0.79	28/760 (3.7)	0.91
6–10	916	− 0.14		17/438 (3.9)		17/478 (3.6)
Gender
Male	932	− 0.15	0.94	12/304 (4.0)	0.92	23/628 (3.7)	0.96
Female	976	− 0.15		15/366 (4.1)		22/610 (3.6)
Had TF at baseline
Yes	55	− 0.01	0.01	0/44 (0.0)	0.25	0/11 (0.0)	1.00
No	1853	− 0.16		27/626 (4.3)		45/1,227 (3.7)
Had infection at baseline
Yes	120	− 0.08	< 0.001	0/114 (0.0)	0.008	5/6 (83.3)	< 0.001
No	1788	− 0.17		27/556 (4.9)		40/1,232 (3.3%)
Communitya prevalence of TF at baseline
0%	848	− 0.18	0.02	18/240 (7.5)	0.001	25/608 (4.1)	0.44
> 0%	1,060	− 0.13		9/430 (2.1)		20/630 (3.2)
Communitya prevalence of infection at baseline
0%	315	− 0.20	0.04	4/77 (5.9)	0.54	7/238 (2.9)	0.70
> 0%	1593	− 0.14		23/593 (3.9)		38/1,000 (3.8)

^aCommunity is defined as the aggregate result from the children in the cohort living in that community.